SIGA Technologies, Inc. announced the appointment of Larry Miller as general counsel, effective 25 March 2024. With over twenty years of experience in the biopharmaceutical industry, Larry brings a proven track record of growing commercial businesses, successful mergers and acquisitions, and strong corporate governance, which are critical to driving SIGAs continued success and growth strategies forward. Previously, Mr. Miller served as general counsel and secretary at Phathom Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of novel treatments for gastrointestinal disorders.

In this role, he provided strategic legal advice in diverse areas including securities, corporate governance, mergers and acquisitions, intellectual property, regulatory strategy, clinical development, and commercialization. He also served as general counsel and secretary at Blue Buffalo Company, advising the company through its $8 billion sale to General Mills. Earlier in his career, he held increasingly senior roles at Pfizer Inc., and was an attorney with Arnold &Porter and Weil, Gotshal &Manges.

Mr. Miller earned his bachelors degree from Dartmouth College and law degree from Columbia Law School.